MEDICENNA THERAPEUTICS CORPMEDICENNA THERAPEUTICS CORPMEDICENNA THERAPEUTICS CORP

MEDICENNA THERAPEUTICS CORP

No trades
See on Supercharts
Market capitalization
‪120.47 M‬CAD
−0.22CAD
‪−10.05 M‬CAD
‪53.13 M‬
Beta (1Y)
1.63

About MEDICENNA THERAPEUTICS CORP

CEO
Fahar Merchant
Headquarters
Toronto
Employees (FY)
17
Founded
2015
ISIN
CA58490H1073
FIGI
BBG008MPLPT2
Medicenna Therapeutics Corp. is a clinical stage immuno-oncology company. It engages in development and commercialization of selective versions of IL-2, IL-4 and IL-13 Superkines and Empowered Cytokines for the treatment of cancers. The company was founded by Fahar Merchant and Rosemina Merchant on February 2, 2015 and is headquartered in Toronto, Canada.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of MDNA is 1.72 CAD — it has decreased by 3.37% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NEO exchange MEDICENNA THERAPEUTICS CORP stocks are traded under the ticker MDNA.
MEDICENNA THERAPEUTICS CORP is going to release the next earnings report on May 17, 2024. Keep track of upcoming events with our Earnings Calendar.
MDNA stock is 3.49% volatile and has beta coefficient of 1.63. Check out the list of the most volatile stocks — is MEDICENNA THERAPEUTICS CORP there?
One year price forecast for MEDICENNA THERAPEUTICS CORP has a max estimate of 8.16 CAD and a min estimate of 1.60 CAD.
MDNA earnings for the last quarter are −0.05 CAD per share, whereas the estimation was −0.06 CAD resulting in a 16.67% surprise. The estimated earnings for the next quarter are −0.07 CAD per share. See more details about MEDICENNA THERAPEUTICS CORP earnings.
MEDICENNA THERAPEUTICS CORP revenue for the last quarter amounts to 0 CAD despite the estimated figure of 0 CAD. In the next quarter revenue is expected to reach ‪250.00 K‬ CAD.
Yes, you can track MEDICENNA THERAPEUTICS CORP financials in yearly and quarterly reports right on TradingView.
MDNA stock has fallen by 14.00% compared to the previous week, the month change is a 20.28% rise, over the last year MEDICENNA THERAPEUTICS CORP has showed a 102.35% increase.
MDNA net income for the last quarter is ‪−4.98 M‬ CAD, while the quarter before that showed ‪−3.72 M‬ CAD of net income which accounts for −33.68% change. Track more MEDICENNA THERAPEUTICS CORP financial stats to get the full picture.
Today MEDICENNA THERAPEUTICS CORP has the market capitalization of ‪116.30 M‬, it has decreased by 8.60% over the last week.
No, MDNA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, MDNA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MEDICENNA THERAPEUTICS CORP stock right from TradingView charts — choose your broker and connect to your account.
MDNA reached its all-time high on Jun 1, 2020 with the price of 7.23 CAD, and its all-time low was 0.22 CAD and was reached on Nov 1, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 19, 2024, the company has 17.00 employees. See our rating of the largest employees — is MEDICENNA THERAPEUTICS CORP on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MEDICENNA THERAPEUTICS CORP technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MEDICENNA THERAPEUTICS CORP stock shows the buy signal. See more of MEDICENNA THERAPEUTICS CORP technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on MEDICENNA THERAPEUTICS CORP future price: according to them, MDNA price has a max estimate of 8.16 CAD and a min estimate of 1.60 CAD. Read a more detailed MEDICENNA THERAPEUTICS CORP forecast: see what analysts think of MEDICENNA THERAPEUTICS CORP and suggest that you do with its stocks.